Skip to main content
Top
Published in: Neurological Sciences 10/2022

18-07-2022 | Care | Original Article

Development and internal validation of a prognostic model for 15-year risk of Alzheimer dementia in primary care patients

Authors: Giulia Grande, Davide L. Vetrano, Ettore Marconi, Elisa Bianchini, Iacopo Cricelli, Valeria Lovato, Luisa Guglielmini, Daiana Taddeo, Stefano F. Cappa, Claudio Cricelli, Francesco Lapi

Published in: Neurological Sciences | Issue 10/2022

Login to get access

Abstract

Background

The exploitation of routinely collected clinical health information is warranted to optimize the case detection and diagnostic workout of Alzheimer’s disease (AD). We aimed to derive an AD prediction score based on routinely collected primary care data.

Methods

We built a cohort selecting 199,978 primary care patients 60 + part of the Health Search Database between January 2002 and 2009, followed up until 2019 to detect incident AD cases. The cohort was randomly divided into a derivation and validation sub-cohort. To identify AD and non-AD cases, we applied a clinical algorithm that involved two clinicians. According to a nested case–control design, AD cases were matched with up to 10 controls based on age, sex, calendar period, and follow-up duration. Using the derivation sub-cohort, 32 potential AD predictors (sociodemographic, clinical, drug-related, etc.) were tested in a logistic regression and selected to build a prediction model. The predictive performance of this model was tested on the validation sub-cohort by mean of explained variation, calibration, and discrimination measurements.

Results

We identified 3223 AD cases. The presence of memory disorders, hallucinations, anxiety, and depression and the use of NSAIDs were associated with future AD. The combination of the predictors allowed the production of a predictive score that showed an explained variation (pseudo-R2) for AD occurrence of 13.4%, good calibration parameters, and an area under the curve of 0.73 (95% CI: 0.71–0.75). In accordance with this model, 7% of patients presented with a high-risk score for developing AD over 15 years.

Conclusion

An automated risk score for AD based on routinely collected clinical data is a promising tool for the early case detection and timely management of patients by the general practitioners.
Appendix
Available only for authorised users
Literature
2.
6.
go back to reference Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H et al (2016) Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol 15:455–532CrossRef Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H et al (2016) Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol 15:455–532CrossRef
7.
go back to reference Anderson RM, Hadjichrysanthou C, Evans S, Wong MM (2017) Why do so many clinical trials of therapies for Alzheimer’s disease fail? Lancet 390:2327–2329CrossRef Anderson RM, Hadjichrysanthou C, Evans S, Wong MM (2017) Why do so many clinical trials of therapies for Alzheimer’s disease fail? Lancet 390:2327–2329CrossRef
8.
go back to reference Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2019) Alzheimer’s disease drug development pipeline: 2019. Alzheimers Dement (N Y) 5:272–293CrossRef Cummings J, Lee G, Ritter A, Sabbagh M, Zhong K (2019) Alzheimer’s disease drug development pipeline: 2019. Alzheimers Dement (N Y) 5:272–293CrossRef
9.
go back to reference Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413–446CrossRef Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 396:413–446CrossRef
10.
go back to reference Dubois B, Padovani A, Scheltens P, Rossi A, Dell’Agnello G (2016) Timely diagnosis for Alzheimer’s disease: a literature review on benefits and challenges. J Alzheimers Dis 49:617–631CrossRef Dubois B, Padovani A, Scheltens P, Rossi A, Dell’Agnello G (2016) Timely diagnosis for Alzheimer’s disease: a literature review on benefits and challenges. J Alzheimers Dis 49:617–631CrossRef
11.
go back to reference Hampel H, O’Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S et al (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14:639–652CrossRef Hampel H, O’Bryant SE, Molinuevo JL, Zetterberg H, Masters CL, Lista S et al (2018) Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat Rev Neurol 14:639–652CrossRef
12.
go back to reference Downs MG (1996) The role of general practice and the primary care team in dementia diagnosis and management. Int J Ger Psychiatry 11:937–942CrossRef Downs MG (1996) The role of general practice and the primary care team in dementia diagnosis and management. Int J Ger Psychiatry 11:937–942CrossRef
13.
go back to reference Grande G, Tramacere I, Vetrano DL, Clerici F, Pomati S, Mariani C, Filippini G, REMIND Study Group (Rete Milanese Integrata per le Demenze) (2017) Role of anticholinergic burden in primary care patients with first cognitive complaints. Eur J Neurol. 24(7):950–955. https://doi.org/10.1111/ene.13313CrossRefPubMed Grande G, Tramacere I, Vetrano DL, Clerici F, Pomati S, Mariani C, Filippini G, REMIND Study Group (Rete Milanese Integrata per le Demenze) (2017) Role of anticholinergic burden in primary care patients with first cognitive complaints. Eur J Neurol. 24(7):950–955. https://​doi.​org/​10.​1111/​ene.​13313CrossRefPubMed
14.
go back to reference Grande G, Vetrano DL, Mazzoleni F, Lovato V, Pata M, Cricelli C, Lapi F (2020) Detection and prediction of incident Alzheimer dementia over a 10-year or longer medical history: a population-based study in primary care. Dement Geriatr Cogn Disord 49(4):384–389. https://doi.org/10.1159/000509379CrossRefPubMed Grande G, Vetrano DL, Mazzoleni F, Lovato V, Pata M, Cricelli C, Lapi F (2020) Detection and prediction of incident Alzheimer dementia over a 10-year or longer medical history: a population-based study in primary care. Dement Geriatr Cogn Disord 49(4):384–389. https://​doi.​org/​10.​1159/​000509379CrossRefPubMed
16.
go back to reference Clift AK et al (2020) Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 371:m3731CrossRef Clift AK et al (2020) Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study. BMJ 371:m3731CrossRef
21.
go back to reference Delaney JA et al (2007) Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord 7:38CrossRef Delaney JA et al (2007) Lifestyle variables and the risk of myocardial infarction in the general practice research database. BMC Cardiovasc Disord 7:38CrossRef
22.
go back to reference Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5:735–741CrossRef Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol 5:735–741CrossRef
23.
go back to reference Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C (2010) Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol 6:318–326CrossRef Stephan BC, Kurth T, Matthews FE, Brayne C, Dufouil C (2010) Dementia risk prediction in the population: are screening models accurate? Nat Rev Neurol 6:318–326CrossRef
25.
go back to reference Grande G, Rizzuto D, Vetrano DL, Marseglia A, Vanacore N, Laukka JE, Welmer AK, Fratiglioni L (2020) Cognitive and physical markers of prodromal dementia: a 12-year-long population study. Alzheimers Dement 16(1):153–161CrossRef Grande G, Rizzuto D, Vetrano DL, Marseglia A, Vanacore N, Laukka JE, Welmer AK, Fratiglioni L (2020) Cognitive and physical markers of prodromal dementia: a 12-year-long population study. Alzheimers Dement 16(1):153–161CrossRef
26.
go back to reference Collins GS, Altman D (2012) Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 344:e4181CrossRef Collins GS, Altman D (2012) Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 344:e4181CrossRef
27.
29.
go back to reference Walters K, Hardoon S, Petersen I et al (2016) Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data. BMC Med 14:6CrossRef Walters K, Hardoon S, Petersen I et al (2016) Predicting dementia risk in primary care: development and validation of the Dementia Risk Score using routinely collected data. BMC Med 14:6CrossRef
33.
go back to reference Dotson VM, Beydoun MA, Zonderman AB (2010 Jul 6) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75(1):27–34CrossRef Dotson VM, Beydoun MA, Zonderman AB (2010 Jul 6) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75(1):27–34CrossRef
34.
go back to reference Brommelhoff JA, Gatz M, Johansson B, McArdle JJ, Fratiglioni L, Pedersen NL (2009) Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins. Psychol Aging 24(2):373–384CrossRef Brommelhoff JA, Gatz M, Johansson B, McArdle JJ, Fratiglioni L, Pedersen NL (2009) Depression as a risk factor or prodromal feature for dementia? Findings in a population-based sample of Swedish twins. Psychol Aging 24(2):373–384CrossRef
35.
go back to reference Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivimaki M et al (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiat 74(7):712–718CrossRef Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivimaki M et al (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiat 74(7):712–718CrossRef
36.
go back to reference Enache D, Winblad B, Aarsland D (2011) Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24(6):461–472CrossRef Enache D, Winblad B, Aarsland D (2011) Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24(6):461–472CrossRef
37.
go back to reference Gallacher J, Bayer A, Fish M et al (2009) Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 71:659–666CrossRef Gallacher J, Bayer A, Fish M et al (2009) Does anxiety affect risk of dementia? Findings from the Caerphilly Prospective Study. Psychosom Med 71:659–666CrossRef
39.
go back to reference Szekely CA, Green RC, Breitner JC, Ostbye T, Beiser AS, Corrada MM et al (2008) No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 70(24):2291–2298CrossRef Szekely CA, Green RC, Breitner JC, Ostbye T, Beiser AS, Corrada MM et al (2008) No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology 70(24):2291–2298CrossRef
40.
go back to reference Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505–522CrossRef Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15:505–522CrossRef
41.
go back to reference Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822–1832CrossRef Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822–1832CrossRef
Metadata
Title
Development and internal validation of a prognostic model for 15-year risk of Alzheimer dementia in primary care patients
Authors
Giulia Grande
Davide L. Vetrano
Ettore Marconi
Elisa Bianchini
Iacopo Cricelli
Valeria Lovato
Luisa Guglielmini
Daiana Taddeo
Stefano F. Cappa
Claudio Cricelli
Francesco Lapi
Publication date
18-07-2022
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 10/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-022-06258-7

Other articles of this Issue 10/2022

Neurological Sciences 10/2022 Go to the issue